Skip to content

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04375241
Acronym
DETECT AF
Enrollment
2168
Registered
2020-05-05
Start date
2018-07-02
Completion date
2021-04-30
Last updated
2022-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Mobile ECG device, Asymptomatic atrial fibrillation

Brief summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all. The main objectives are: * To examine the feasibility of screening subjects of ≥65 years old for AAF. * To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.

Detailed description

Study design: Prospective validation study.

Interventions

OTHERSubjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Sponsors

Diagram B.V.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥65 years * Is willing to give informed consent

Exclusion criteria

* Known medical history with Atrial Fibrillation * Not mental competent

Design outcomes

Primary

MeasureTime frame
Sensitivity of the mobile ECG deviceAt screening
Specificity of the mobile ECG deviceAt screening

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026